Status and Challenges of Care in Africa for Adults With Congenital Heart Defects

Frank Edwin1,2, Liesl Zühlke3,4, Heba Farouk5

  • 11 National Cardiothoracic Center, Korle Bu Teaching Hospital, Accra, Ghana.

Insights

Africa faces a significant burden of congenital heart defects (CHD), with over 300,000 new cases annually. Inadequate healthcare systems result in CHD being a pediatric issue, straining resources as Africa

Area of Science:

  • Public Health
  • Pediatrics
  • Cardiology

Background:

  • An estimated 300,486 annual congenital heart defect (CHD) births occur across Africa.
  • Over half of these cases are concentrated in just seven African nations.
  • CHD is predominantly a pediatric concern due to underdeveloped healthcare infrastructure, limiting adult care.

Purpose of the Study:

  • To highlight the substantial burden of congenital heart defects in Africa.
  • To underscore the challenges posed by deficient healthcare systems in managing CHD.
  • To project the future strain on CHD care systems given Africa's population growth.

Main Methods:

  • Analysis of estimated birth prevalence data for congenital heart defects across 54 African countries.
  • Examination of the proportion of adult patients within CHD cases in specific countries (Ghana, Mozambique).
  • Consideration of projected population growth in Africa.

Main Results:

  • Estimated 300,486 annual CHD births in Africa.
  • High concentration of cases in specific countries (51.4% in seven nations).
  • Low adult representation in CHD patient populations (e.g., 10% in Ghana, 13.7% in Mozambique surgical cases).

Conclusions:

  • Congenital heart disease presents a major public health challenge in Africa.
  • Existing healthcare systems are ill-equipped to manage the current and future CHD burden.
  • Urgent, decisive action from African leaders is critical to address the escalating crisis.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
419
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
466